14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $141.16 $183.01 Friday, 3rd May 2024 ADXS stock ended at $0.555. This is 4.62% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 4.67% from a day low at $0.535 to a day high of $0.560.
90 days $141.16 $227.30
52 weeks $84.73 $227.30

Historical Advaxis prices

Date Open High Low Close Volume
Jun 18, 2020 $0.618 $0.645 $0.615 $0.632 866 805
Jun 17, 2020 $0.631 $0.660 $0.610 $0.638 1 193 449
Jun 16, 2020 $0.667 $0.678 $0.640 $0.650 1 649 089
Jun 15, 2020 $0.650 $0.678 $0.630 $0.657 1 190 722
Jun 12, 2020 $0.700 $0.700 $0.630 $0.660 2 846 193
Jun 11, 2020 $0.750 $0.80 $0.600 $0.650 7 772 506
Jun 10, 2020 $0.85 $0.87 $0.80 $0.85 1 539 678
Jun 09, 2020 $0.85 $0.85 $0.773 $0.84 1 061 418
Jun 08, 2020 $0.82 $0.84 $0.792 $0.84 2 138 303
Jun 05, 2020 $0.770 $0.780 $0.740 $0.776 965 515
Jun 04, 2020 $0.780 $0.790 $0.732 $0.758 1 216 636
Jun 03, 2020 $0.81 $0.83 $0.751 $0.782 2 433 534
Jun 02, 2020 $0.716 $0.80 $0.700 $0.771 1 756 472
Jun 01, 2020 $0.700 $0.715 $0.660 $0.710 735 792
May 29, 2020 $0.705 $0.710 $0.650 $0.686 1 102 967
May 28, 2020 $0.710 $0.717 $0.693 $0.693 539 585
May 27, 2020 $0.702 $0.715 $0.670 $0.710 1 132 750
May 26, 2020 $0.719 $0.730 $0.698 $0.698 936 855
May 22, 2020 $0.740 $0.740 $0.695 $0.709 881 170
May 21, 2020 $0.719 $0.759 $0.711 $0.724 943 079
May 20, 2020 $0.732 $0.740 $0.690 $0.710 1 043 521
May 19, 2020 $0.740 $0.740 $0.707 $0.720 569 203
May 18, 2020 $0.791 $0.791 $0.700 $0.721 1 259 897
May 15, 2020 $0.720 $0.755 $0.704 $0.734 840 481
May 14, 2020 $0.710 $0.750 $0.689 $0.706 813 319
Click to get the best stock tips daily for free!

About Advaxis

Advaxis Advaxis, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of proprietary Listeria monocytogenes (Lm) technology antigen delivery products in the United States. The company is developing ADXS-PSA, which is in Phase 2 clinical trials for the treatment of metastatic prostate cancer; ADXS-503 that is in Phase 1/2 clinical trials for the treatment of non-small cell lung cancer; and ADXS-504 for... ADXS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT